The National Agency for Food and Drug Administration and Control (NAFDAC) has raised an urgent public alert on the circulation of falsified batches of Postinor-2 (Levonorgestrel 0.75mg), a widely used brand of emergency contraceptive pill in Nigeria.
In a statement issued by the agency, NAFDAC disclosed that the falsified products identified as Type 1 and Type 2 have infiltrated the Nigerian market, posing serious health risks to unsuspecting consumers.
According to NAFDAC, the falsified Postinor-2 packs were discovered during routine market surveillance and do not meet the required quality, safety, and efficacy standards. The agency emphasized that consumption of counterfeit contraceptives may result in unwanted pregnancies, complications, and other severe health consequences.
“The circulation of falsified Postinor-2 is a grave public health concern. We urge the public, healthcare providers, and distributors to be extremely vigilant and ensure that contraceptive products are purchased only from licensed pharmacies and authorized outlets,” the agency warned.
NAFDAC further advised Nigerians to always check that Postinor-2 and other regulated medicines bear genuine NAFDAC registration numbers and intact packaging before use.
The agency encouraged members of the public in possession of the falsified products to immediately stop using them and report to the nearest NAFDAC office, state coordinator, or via the agency’s MedSafety App.
Postinor-2, containing Levonorgestrel 0.75mg, is an emergency contraceptive pill intended to prevent pregnancy when taken within 72 hours after unprotected sexual intercourse. It is one of the most popular contraceptives in Nigeria, making it a frequent target for counterfeiters.
NAFDAC reiterated its commitment to safeguarding the health of Nigerians by intensifying surveillance and collaborating with international regulatory bodies to track and remove falsified medicines from circulation.
